DK1981504T3 - Thiadiazol-derivater til behandling af neurodegenerative sygdomme - Google Patents
Thiadiazol-derivater til behandling af neurodegenerative sygdommeInfo
- Publication number
- DK1981504T3 DK1981504T3 DK07711455.1T DK07711455T DK1981504T3 DK 1981504 T3 DK1981504 T3 DK 1981504T3 DK 07711455 T DK07711455 T DK 07711455T DK 1981504 T3 DK1981504 T3 DK 1981504T3
- Authority
- DK
- Denmark
- Prior art keywords
- disease
- treatment
- thiadiazole derivatives
- neurodegenerative diseases
- syndrome
- Prior art date
Links
- 230000004770 neurodegeneration Effects 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
- 150000004867 thiadiazoles Chemical class 0.000 title 1
- YGTAZGSLCXNBQL-UHFFFAOYSA-N 1,2,4-thiadiazole Chemical class C=1N=CSN=1 YGTAZGSLCXNBQL-UHFFFAOYSA-N 0.000 abstract 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 206010067889 Dementia with Lewy bodies Diseases 0.000 abstract 1
- 201000010374 Down Syndrome Diseases 0.000 abstract 1
- 208000009829 Lewy Body Disease Diseases 0.000 abstract 1
- 208000001089 Multiple system atrophy Diseases 0.000 abstract 1
- 208000014060 Niemann-Pick disease Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000030886 Traumatic Brain injury Diseases 0.000 abstract 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 abstract 1
- 208000033510 neuroaxonal dystrophy Diseases 0.000 abstract 1
- 208000002593 pantothenate kinase-associated neurodegeneration Diseases 0.000 abstract 1
- 230000009529 traumatic brain injury Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0602335.2A GB0602335D0 (en) | 2006-02-07 | 2006-02-07 | Thiadiazole Derivatives For The Treatment Of Neurodegenerative Diseases |
| PCT/EP2007/001022 WO2007090617A2 (en) | 2006-02-07 | 2007-02-07 | Thiadiazole derivatives for the treatment of neuro degenerative diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1981504T3 true DK1981504T3 (da) | 2010-11-08 |
Family
ID=36101115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07711455.1T DK1981504T3 (da) | 2006-02-07 | 2007-02-07 | Thiadiazol-derivater til behandling af neurodegenerative sygdomme |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1981504B1 (da) |
| JP (1) | JP5283511B2 (da) |
| CN (1) | CN101378757B (da) |
| AT (1) | ATE474579T1 (da) |
| AU (1) | AU2007213954B2 (da) |
| BR (1) | BRPI0707700B8 (da) |
| CA (1) | CA2641453C (da) |
| DE (1) | DE602007007890D1 (da) |
| DK (1) | DK1981504T3 (da) |
| EA (1) | EA018067B1 (da) |
| ES (1) | ES2348999T3 (da) |
| GB (1) | GB0602335D0 (da) |
| HK (1) | HK1122989A1 (da) |
| PL (1) | PL1981504T3 (da) |
| PT (1) | PT1981504E (da) |
| WO (1) | WO2007090617A2 (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2137162B1 (en) * | 2007-03-15 | 2018-08-01 | Novartis AG | Organic compounds and their uses |
| US20090325964A1 (en) * | 2008-05-23 | 2009-12-31 | Wyeth | Piperazine Metabotropic Glutamate Receptor 5 (MGLUR5) Negative Allosteric Modulators For Anxiety/Depression |
| CN102066347B (zh) | 2008-06-27 | 2016-06-08 | 拜耳知识产权有限责任公司 | 噻二唑氧苯基脒及其作为杀菌剂的应用 |
| BRPI1014604A2 (pt) | 2009-05-04 | 2016-04-05 | Basf Corp | composição de catalisador, e, método para tratar uma corrente de gás de descarga |
| GB201106817D0 (en) | 2011-04-21 | 2011-06-01 | Astex Therapeutics Ltd | New compound |
| JP5972367B2 (ja) * | 2011-07-01 | 2016-08-17 | リマインド・ナムローゼ・フエンノートシャップＲｅｍｙｎｄ Ｎｖ | 神経変性疾患の治療に有用な１，２，４−チアジアゾール−５−イルピペラジン誘導体 |
| AU2012296804B2 (en) * | 2011-08-17 | 2017-04-20 | Remynd Nv | Piperazine thiazole derivatives useful in the treatment of tauopathies such as alzheimer's disease |
| GB201218862D0 (en) | 2012-10-19 | 2012-12-05 | Astex Therapeutics Ltd | Bicyclic heterocycle compounds and their uses in therapy |
| GB201218864D0 (en) | 2012-10-19 | 2012-12-05 | Astex Therapeutics Ltd | Bicyclic heterocycle compounds and their uses in therapy |
| GB201218850D0 (en) | 2012-10-19 | 2012-12-05 | Astex Therapeutics Ltd | Bicyclic heterocycle compounds and their uses in therapy |
| US9980973B2 (en) | 2012-10-19 | 2018-05-29 | Astex Therapeutics Limited | Bicyclic heterocycle compounds and their uses in therapy |
| CN105829310B (zh) | 2013-12-20 | 2019-04-12 | 阿斯特克斯治疗有限公司 | 双环杂环化合物及其治疗用途 |
| US10562869B2 (en) | 2014-03-17 | 2020-02-18 | Remynd Nv | Oxadiazole compounds |
| JP7178831B2 (ja) | 2018-08-30 | 2022-11-28 | 日本特殊陶業株式会社 | 基板保持部材 |
| AU2021324684A1 (en) * | 2020-08-11 | 2023-04-20 | Board Of Trustees Of Michigan State University | Proteasome enhancers and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6060472A (en) | 1998-04-06 | 2000-05-09 | Apotex Inc. | Thiadiazole compounds useful as inhibitors of H+ /K+ atpase |
| WO2002083863A2 (en) * | 2001-04-17 | 2002-10-24 | Sepracor, Inc. | Thiazole and other heterocyclic ligands and use thereof |
| CA2534532A1 (en) * | 2003-08-21 | 2005-03-10 | Pfizer Products, Inc. | Compounds for the treatment of neurodegenerative disorders |
| US7232820B2 (en) * | 2004-04-01 | 2007-06-19 | Pfizer Inc | Thiadiazole-amine compounds for the treatment of neurodegenerative disorders |
| DE102004032567A1 (de) * | 2004-07-05 | 2006-03-02 | Grünenthal GmbH | Substituierte 1-Propiolyl-piperazine |
-
2006
- 2006-02-07 GB GBGB0602335.2A patent/GB0602335D0/en not_active Ceased
-
2007
- 2007-02-07 EA EA200870233A patent/EA018067B1/ru not_active IP Right Cessation
- 2007-02-07 DK DK07711455.1T patent/DK1981504T3/da active
- 2007-02-07 AU AU2007213954A patent/AU2007213954B2/en not_active Ceased
- 2007-02-07 PT PT07711455T patent/PT1981504E/pt unknown
- 2007-02-07 CA CA2641453A patent/CA2641453C/en active Active
- 2007-02-07 BR BRPI0707700A patent/BRPI0707700B8/pt not_active IP Right Cessation
- 2007-02-07 DE DE602007007890T patent/DE602007007890D1/de active Active
- 2007-02-07 EP EP07711455A patent/EP1981504B1/en active Active
- 2007-02-07 JP JP2008553672A patent/JP5283511B2/ja not_active Expired - Fee Related
- 2007-02-07 AT AT07711455T patent/ATE474579T1/de active
- 2007-02-07 PL PL07711455T patent/PL1981504T3/pl unknown
- 2007-02-07 CN CN2007800045833A patent/CN101378757B/zh not_active Expired - Fee Related
- 2007-02-07 WO PCT/EP2007/001022 patent/WO2007090617A2/en active Application Filing
- 2007-02-07 ES ES07711455T patent/ES2348999T3/es active Active
-
2009
- 2009-01-08 HK HK09100186.5A patent/HK1122989A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0707700B8 (pt) | 2022-12-20 |
| HK1122989A1 (en) | 2009-06-05 |
| PT1981504E (pt) | 2010-10-13 |
| EA018067B1 (ru) | 2013-05-30 |
| ES2348999T3 (es) | 2010-12-21 |
| WO2007090617A2 (en) | 2007-08-16 |
| EP1981504A2 (en) | 2008-10-22 |
| AU2007213954B2 (en) | 2011-09-22 |
| CA2641453C (en) | 2013-07-30 |
| CA2641453A1 (en) | 2007-08-16 |
| BRPI0707700B1 (pt) | 2020-08-04 |
| JP2009526000A (ja) | 2009-07-16 |
| CN101378757B (zh) | 2012-08-01 |
| EA200870233A1 (ru) | 2009-02-27 |
| JP5283511B2 (ja) | 2013-09-04 |
| WO2007090617A3 (en) | 2008-02-28 |
| CN101378757A (zh) | 2009-03-04 |
| PL1981504T3 (pl) | 2010-12-31 |
| AU2007213954A1 (en) | 2007-08-16 |
| BRPI0707700A2 (pt) | 2011-05-10 |
| ATE474579T1 (de) | 2010-08-15 |
| GB0602335D0 (en) | 2006-03-15 |
| DE602007007890D1 (de) | 2010-09-02 |
| EP1981504B1 (en) | 2010-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1981504T3 (da) | Thiadiazol-derivater til behandling af neurodegenerative sygdomme | |
| EP1986639A4 (en) | PHARMACEUTICAL COMPOSITIONS OF DEXTROMETHORPHANE AND CHINIDINE FOR THE TREATMENT OF DEPRESSION, FEAR STATES AND NEURODEEGENERATIVE DISEASES | |
| BRPI0818799A2 (pt) | Composições para o tratamento da doença de parkinson | |
| IL195256A0 (en) | Compositions of r(+)and s(-)pramipexole and methods of using the same | |
| IL189622A0 (en) | Pharmaceutical compositions for the treatment of inner ear disorders | |
| UA109878C2 (uk) | Похідні ізохінолінону, фармацевтична композиція на їх основі (варіанти) та спосіб лікування захворювань (варіанти) | |
| TW200738724A (en) | Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
| WO2006119295A3 (en) | Compositions and methods for the treatment of neurodegenerative diseases | |
| CL2011001098A1 (es) | Compuestos derivados de 4-fluoro-1h-isoindol-3-amina; inhibidores de b-secretasa (bace); composicion farmaceutica; y su uso para el tratamiento o prevencion de una patologia relacionada con la proteina beta amiloide tal como sindrome de down, alzheimer, demencia senil y demencia asociada con parkinson, entre otras. | |
| WO2009071689A3 (de) | 5-halogen-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen | |
| TN2010000155A1 (en) | Organic compounds | |
| BRPI0608437A2 (pt) | derivados tiazol fundidos que possuem afinidade para o receptor histamina h3 | |
| ATE495164T1 (de) | Thiadiazolderivate zur behandlung neurodegenerativer krankheiten | |
| WO2009019295A3 (en) | Phenyl- and benzylthiazolylpiperazine derivatives for the treatment of neurodegenerative diseases | |
| NL1033562A1 (nl) | Tetrahydropyridoazepine-8-onen en verwante verbindingen voor de behandeling van schizofrenie. | |
| MX340564B (es) | Isoformas de neurregulina solubles activas modificadas post-traduccionalmente. | |
| ATE450273T1 (de) | Proliferationshemmendes arzneimittel | |
| DE502007002949D1 (de) | Proteinbindende methotrexat-derivate und diese enthaltende arzneimittel | |
| WO2009134668A3 (en) | 4-oxo-1,4-dihydroquinoline m1 receptor positive allosteric modulators | |
| WO2008099083A3 (fr) | Utilisation de composes neuroprotecteurs pour l'obtention de médicaments destines au traitement de maladies neurodegeneratives | |
| WO2009051661A3 (en) | Substituted aryl alkylamino-oxy-analogs and uses thereof | |
| FR2918281B1 (fr) | Medicament pour le traitement de la maladie de parkinson. | |
| WO2009140649A3 (en) | Rab3b for the treatment and prevention of parkinson's disease | |
| WO2008112701A3 (en) | G-substrate for the treatment and prevention of parkinson's disease | |
| WO2008136850A3 (en) | Cobalamin conjugates useful as imaging and therapeutic agents |